The PREDNOS 2 trial team are always here to help. For further information about the PREDNOS 2 trial please contact us:
General enquiries
For general queries about the study, site set-up and queries about collection of data and data anaylsis please contact the Birmingham Clinical Trials Unit.
Email: prednos2@trials.bham.ac.uk
Postal address:
PREDNOS 2 Trial Office
Birmingham Clinical Trials Unit
Robert Aitken Institute
College of Medical and Dental Sciences
University of Birmingham
Edgbaston
Birmingham B15 2TT
Freepost address:
PREDNOS 2 Trial Office
FREEPOST RRKR-JUZR-HZHG
Birmingham Clinical Trials Unit
Robert Aitken Institute
College of Medical and Dental Sciences
University of Birmingham
Edgbaston
Birmingham B15 2TT
PREDNOS 2 trial staff:
Elizabeth Brettell Trials Manager 0121 415 9130
Noreen Akhtar Trials Administrator 0121 415 9131
Emma Barsoum Trial Coordinator 0121 415 9133
Gemma Ryan Data Manager 0121 415 9134
Charmaine Meek Data Manager 0121 415 9132
Terry Hughes Data Manager 0121 415 9131
......................................................................................................................................................................
Find out more information about our other renal trials and the University of Birmingham Clinical Trials Unit below:
BCTU
The University of Birmingham Clinical Trials Unit (BCTU) is a Research Unit within the School of Medicine specialising in the design, conduct and analysis of clinical trials.
GloMY
GloMY is national, multi-centre, randomised controlled open-label pilot trial of Myfortic plus short course steroids versus standard care in patients with proteinuric primary focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN).
PEXIVAS
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: an international randomised controlled trial.
PREDNOS
Long-term tapering versus standard prednisolone (steroid) therapy for the treatment of the initial episode of childhood nephrotic syndrome: national multicentre randomised double blind trial